Here we have global shares, commodities, high yield, emerging market and frontier market measures (biotech is marked invisible) set against the S&P 500. These are all varying intensity risk benchmarks, and their performance for the past quarter and year has shown a distinctive conformity. Risk aversion is likely to take the torch on major market moves heading into the final months of 2015.